Nutriband (NASDAQ:NTRB) Stock Price Down 8.1% – Here’s What Happened

Nutriband Inc. (NASDAQ:NTRB)’s share price traded down 8.1% on Tuesday . The stock traded as low as $5.52 and last traded at $5.82. 18,083 shares were traded during mid-day trading, a decline of 51% from the average session volume of 36,552 shares. The stock had previously closed at $6.33.

Nutriband Stock Performance

The company has a quick ratio of 6.36, a current ratio of 6.57 and a debt-to-equity ratio of 0.01. The firm has a 50-day moving average price of $5.69 and a 200 day moving average price of $5.38. The firm has a market capitalization of $64.23 million, a PE ratio of -7.56 and a beta of 1.12.

Nutriband (NASDAQ:NTRB) last released its earnings results on Tuesday, September 3rd. The company reported ($0.12) earnings per share for the quarter. The firm had revenue of $0.44 million during the quarter. Nutriband had a negative net margin of 401.39% and a negative return on equity of 66.60%.

Institutional Trading of Nutriband

An institutional investor recently bought a new position in Nutriband stock. Virtu Financial LLC acquired a new stake in Nutriband Inc. (NASDAQ:NTRB) during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 12,862 shares of the company’s stock, valued at approximately $58,000. Virtu Financial LLC owned about 0.12% of Nutriband at the end of the most recent quarter. 19.70% of the stock is currently owned by hedge funds and other institutional investors.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.